The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
Embracing cancer complexity: Hallmarks of systemic disease
Open accessAbstract
SUMMARY The last 50 years have witnessed extraordinary developments in understanding mechanisms of carcinogenesis, synthesized as the hallmarks of cancer. Despite this logical framework, our understanding of the molecular basis of systemic manifestations and the underlying causes of cancer-related death remains incomplete. Looking forward, elucidating how tumors interact with distant organs and how multifaceted environmental and physiological parameters impinge on tumors and their hosts will be crucial for advances in preventing and more effectively treating human cancers. In this perspective, we discuss complexities of cancer as a systemic disease, including tumor initiation and promotion, tumor micro- and immune macro-environments, aging, metabolism and obesity, cancer cachexia, circadian rhythms, nervous system interactions, tumor-related thrombosis, and the microbiome. Model systems incorporating human genetic variation will be essential to decipher the mechanistic basis of these phenomena and unravel gene-environment interactions, providing a modern synthesis of molecular oncology that is primed to prevent cancers and improve patient quality of life and cancer outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–256 of 256
Disruption of the circadian clock drives Apc loss of heterozygosity to accelerate colorectal cancer
Chun, S. K., Fortin, B. M., Fellows, R. C., Habowski, A. N., Verlande, A., Song, W. A., Mahieu, A. L., Lefebvre, A. E. Y. T., Sterrenberg, J. N., Vélez, L. M., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo2389 · Cited by 119
Organism-wide, cell-type-specific secretome mapping of exercise training in mice
Wei, W., Riley, N. M., Lyu, X., Shen, X., Guo, J., Raun, S. H., Zhao, M., Moya-Garzón, M. D., Basu, H., Tung, A. S.-H., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.04.011 · Cited by 108
Neoadjuvant Therapy as a Platform for Drug Development and Approval in Breast Cancer
Bardia, A., & Baselga, J. M. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0916 · Cited by 107
Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site
Fowler, J. C., King, C., Bryant, C., Hall, M., Sood, R. K., Ong, S. H., Earp, E., Fernández‐Antorán, D., Koeppel, J., Dentro, S. C., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1092 · Cited by 102
Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed
Brennan, P., & Smith, G. D. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab204 · Cited by 102
Cancer in the Fourth Dimension: What Is the Impact of Circadian Disruption?
Pariollaud, M., & Lamia, K. A. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0413 · Cited by 101
Self-citationHaroun, R., Wood, J. N., & Sikandar, S. (2023) · Frontiers in Pain Research · doi:10.3389/fpain.2022.1030899 · Cited by 101
Self-citationKadariya, Y., Menges, C. W., Talarchek, J. N., Cai, K. Q., Klein–Szanto, A. J., Pietrofesa, R. A., Christofidou‐Solomidou, M., Cheung, M., Mossman, B. T., Shukla, A., et al. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0347 · Cited by 97
Turrell, F. K., Orha, R., Guppy, N., Gillespie, A., Guelbert, M., Starling, C., Haider, S., & Isacke, C. M. (2023) · Nature Cancer · doi:10.1038/s43018-023-00525-y · Cited by 96
Tawil, N., Bassawon, R., Meehan, B., Nehme, A., Montermini, L., Gayden, T., Jay, N. D., Spinelli, C., Chennakrishnaiah, S., Choi, D., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002998 · Cited by 91
The virtuous cycle of human genetics and mouse models in drug discovery
Nadeau, J. H., & Auwerx, J. H. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0009-9 · Cited by 83
Self-citationThe heightened importance of the microbiome in cancer immunotherapy
Villemin, C., Six, A., Neville, B. A., Lawley, T. D., Robinson, M. J., & Bakdash, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.11.002 · Cited by 81
Burfeind, K. G., Zhu, X., Norgard, M. A., Levasseur, P. R., Huisman, C., Buenafe, A. C., Olson, B. G., Michaelis, K. A., Torres, E. R. S., Jeng, S., et al. (2020) · eLife · doi:10.7554/elife.54095 · Cited by 80
Croci, D., Méndez, R. S., Temme, S., Soukup, K., Fournier, N., Zomer, A., Colotti, R., Wischnewski, V., Flögel, U., van Heeswijk, R. B., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo2952 · Cited by 80
Self-citationValdemarin, F., Caffa, I., Persia, A., Cremonini, A. L., Ferrando, L., Tagliafico, L., Tagliafico, A. S., Guijarro, A. I., Carbone, F., Ministrini, S., et al. (2021) · Cancers · doi:10.3390/cancers13164013 · Cited by 77
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis
Wang, L., Jin, H., Jochems, F., Wang, S., Lieftink, C., Martinez, I. M., Conti, G. D., Edwards, F., de Oliveira, R. L., Schepers, A. G., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00462-2 · Cited by 76
Self-citationInnominato, P. F., Ballesta, A., Huang, Q., Focan, C., Chollet, P. J. M., Karaboué, A., Giacchetti, S., Bouchahda, M., Adam, R. A., Garufi, C., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3056 · Cited by 71
Advances in Small-Cell Lung Cancer (SCLC) Translational Research
Drapkin, B. J., & Rudin, C. M. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a038240 · Cited by 68
Heuer, S., Burghaus, I., Gose, M., Keßler, T., Sahm, F., Vollmuth, P., Venkataramani, V., Hoffmann, D. C., Schlesner, M., Ratliff, M., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-11846-1 · Cited by 68
Self-citationParadoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
Dias, M. H., Friskes, A., Wang, S., Neto, J. M. F., van Gemert, F. P. A., Mourragui, S. M. C., Papagianni, C., Kuiken, H. J., Mainardi, S., Villanueva, D. A., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0216 · Cited by 67
Self-citationClonal Hematopoiesis and Its Impact on Human Health
Ahmad, H., Jahn, N., & Jaiswal, S. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-112347 · Cited by 66
Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect
Baruch, E. N., Wang, J., & Wargo, J. A. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0877 · Cited by 61
Self-citationCircadian disruption enhances HSF1 signaling and tumorigenesis in Kras -driven lung cancer
Pariollaud, M., Ibrahim, L. H., Irizarry, E., Mello, R. M., Chan, A. B., Altman, B. J., Shaw, R. J., Bollong, M. J., Wiseman, R. L., & Lamia, K. A. (2022) · Science Advances · doi:10.1126/sciadv.abo1123 · Cited by 60
Self-citationRevisiting the intrinsic mycobiome in pancreatic cancer
Fletcher, A. A., Kelly, M. S., Eckhoff, A. M., & Allen, P. J. (2023) · Nature · doi:10.1038/s41586-023-06292-1 · Cited by 59
Local Anesthetic Lidocaine and Cancer: Insight Into Tumor Progression and Recurrence
Zhang, C., Xie, C., & Lu, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.669746 · Cited by 58
Circadian regulation of c-MYC in mice
Liu, Z., Selby, C. P., Yang, Y., Lindsey‐Boltz, L. A., Cao, X., Eynullazada, K., & Sancar, A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011225117 · Cited by 56
Álvarez-Prado, Á. F., Maas, R. R., Soukup, K., Klemm, F., Kornete, M., Krebs, F. S., Zoete, V., Berezowska, S., Brouland, J., Hottinger, A. F., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100900 · Cited by 56
Self-citationCaution regarding the specificities of pan-cancer microbial structure
Gihawi, A., Cooper, C. S., & Brewer, D. S. (2023) · Microbial Genomics · doi:10.1099/mgen.0.001088 · Cited by 55
Chiorazzi, M., Martínek, J., Krasnick, B. A., Zheng, Y., Robbins, K. J., Qu, R., Kaufmann, G., Skidmore, Z. L., Juric, M., Henze, L. A., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-006921 · Cited by 48
Tet2 Inactivation Enhances the Antitumor Activity of Tumor-Infiltrating Lymphocytes
Lee, M., Li, J., Li, J., Fang, S., Zhang, J., Vo, A. T. T., Han, W., Zeng, H., Isgandarova, S., Martinez-Moczygemba, M., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3213 · Cited by 47
Biavasco, R., Lettera, E., Giannetti, K., Gilioli, D., Beretta, S., Conti, A., Scala, S., Cesana, D., Gallina, P., Norelli, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24876-1 · Cited by 47
Somatic Mutation: What Shapes the Mutational Landscape of Normal Epithelia?
Fowler, J. C., & Jones, P. H. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0145 · Cited by 45
Neyroud, D., Laitano, O., Dasgupta, A., Lopez, C., Schmitt, R. E., Schneider, J. Z., Hammers, D. W., Sweeney, H. L., Walter, G. A., Doles, J. D., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04902-2 · Cited by 45
Metabolite activation of tumorigenic signaling pathways in the tumor microenvironment
Low, V., Li, Z., & Blenis, J. (2022) · Science Signaling · doi:10.1126/scisignal.abj4220 · Cited by 44
Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic Cells
Cai, Z., Aguilera, F., Ramdas, B., Daulatabad, S. V., Srivastava, R., Kotzin, J. J., Carroll, M. P., Wertheim, G. B. W., Williams, A., Janga, S. C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107816 · Cited by 43
CRY2 missense mutations suppress P53 and enhance cell growth
Chan, A. B., Parico, G. C. G., Fribourgh, J. L., Ibrahim, L. H., Bollong, M. J., Partch, C. L., & Lamia, K. A. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101416118 · Cited by 43
Self-citationHot Tea Consumption and Esophageal Cancer Risk: A Meta-Analysis of Observational Studies
Luo, H., & Ge, H. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.831567 · Cited by 43
Marongiu, F., & DeGregori, J. V. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13275 · Cited by 43
Self-citationThe Multifaceted Role of HSF1 in Tumorigenesis
Alasady, M. J., & Mendillo, M. L. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-40204-4_5 · Cited by 42
Cancer cachexia: involvement of an expanding macroenvironment
Pryce, B. R., Wang, J., Zimmers, T. A., Ostrowski, M. C., & Guttridge, D. C. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.007 · Cited by 42
Verlande, A., Chun, S. K., Goodson, M. O., Fortin, B. M., Bae, H., Jang, C., & Masri, S. (2021) · Science Advances · doi:10.1126/sciadv.abf3885 · Cited by 38
Goldman, O., Adler, L. N., Hajaj, E., Croese, T., Darzi, N., Galai, S., Tishler, H., Ariav, Y., Lavie, D., Fellus-Alyagor, L., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-1062 · Cited by 36
Self-citationSystems Biology Understanding of the Effects of Lithium on Cancer
Ge, W., & Jakobsson, E. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00296 · Cited by 33
Diet and Exercise in Cancer Metabolism
Locasale, J. W. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0096 · Cited by 31
Self-citationConserved multi-tissue transcriptomic adaptations to exercise training in humans and mice
Moore, T. M., Lee-Ødegård, S., Olsén, T., Morselli, M., Strumwasser, A. R., Lin, A. J., Zhou, Z., Abrishami, A. D., Garcia, S. M., Bribiesca, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112499 · Cited by 31
Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery
Marron, T. U., Galsky, M. D., Taouli, B., Fiel, M. I., Ward, S., Kim, E., Yankelevitz, D., Doroshow, D., Guttman-Yassky, E., Ungar, B., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01681-x · Cited by 30
Protocol for ex vivo culture of patient-derived tumor fragments
Roelofsen, L. M., Voabil, P., de Bruijn, M. J. W., Herzig, P., Zippelius, A., Schumacher, T. N., & Thommen, D. S. (2023) · STAR Protocols · doi:10.1016/j.xpro.2023.102282 · Cited by 29
Holt, R. A. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2022.11.014 · Cited by 26
A Collaborative Model for Accelerating the Discovery and Translation of Cancer Therapies
Maertens, O., McCurrach, M. E., Braun, B. S., Raedt, T. D., Epstein, I., Huang, T. Q., Lauchle, J., Lee, H.-R., Wu, J., Cripe, T. P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1789 · Cited by 25
Playing cancer at its own game: activating mitogenic signaling as a paradoxical intervention
Dias, M. H., & Bernards, R. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12979 · Cited by 22
Self-citationA View on Drug Development for Cancer Prevention
Reynolds, A. R., Moschetta, M., Yohannes, A. R., Walcott, F. L., Ashford, M. B., Szűcs, Z., Sarbajna, T., Hadfield, J., Harrison, E., Challis, B., et al. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0776 · Cited by 21
Developing Anticancer Drugs in Orphan Molecular Entities — A Paradigm under Construction
André, F. (2018) · New England Journal of Medicine · doi:10.1056/nejme1716821 · Cited by 20
Self-citationDu, Z., Zhang, H., Feng, Y., Zhan, D., Li, S., Tu, C., Liu, J., & Wang, J. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02175-4 · Cited by 17
Reply to: Revisiting the intrinsic mycobiome in pancreatic cancer
Xu, F., Saxena, D., Pushalkar, S., & Miller, G. (2023) · Nature · doi:10.1038/s41586-023-06293-0 · Cited by 12
Chemoprevention in Barrett’s esophagus and esophageal adenocarcinoma
Alkhayyat, M. M., Kumar, P., SANAKA, K. O., & Thota, P. N. (2021) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848211033730 · Cited by 11
The aging lung reawakens dormant tumor cells
Drápela, S., & Gomes, A. P. (2023) · Nature Cancer · doi:10.1038/s43018-023-00537-8 · Cited by 4
Cited by
Breast cancer: pathogenesis and treatments
Xiong, X., Zheng, L.-W., Ding, Y., Chen, Y.-F., Cai, Y.-W., Wang, L.-P., Huang, L., Liu, C.-C., Shao, Z.-M., & Yu, K.-D. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02108-4 · Cited by 958
Cold and hot tumors: from molecular mechanisms to targeted therapy
Wu, B., Zhang, B., Li, B., Wu, H., & Jiang, M. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01979-x · Cited by 682
Towards targeting the breast cancer immune microenvironment
Harris, M. A., Savas, P., Virassamy, B., O’Malley, M. M. R., Kay, J., Mueller, S. N., Mackay, L. K., Salgado, R., & Loi, S. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00714-6 · Cited by 363
Self-citationMa, Z., Zuo, T., Frey, N., & Rangrez, A. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01946-6 · Cited by 259
Advances in molecular pathology and therapy of non-small cell lung cancer
Huang, Q., Li, Y., Huang, Y., Wu, J., Bao, W., Xue, C., Li, X., Dong, S., Dong, Z., & Hu, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02243-6 · Cited by 197
Metadata
- Authors
- Swanton, C., Bernard, E., Abbosh, C., André, F., Auwerx, J., Balmain, A., Bar-Sagi, D., Bernards, R., Bullman, S., DeGregori, J., Elliott, C., Erez, A., Evan, G., Febbraio, M. A., Hidalgo, A., Jamal-Hanjani, M., Joyce, J. A., Kaiser, M., Lamia, K., Locasale, J. W., Loi, S., Malanchi, I., Merad, M., Musgrave, K., Patel, K. J., Quezada, S., Wargo, J. A., Weeraratna, A., White, E., Winkler, F., Wood, J. N., Vousden, K. H., & Hanahan, D.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2024-03
- Volume
- 187
- Issue
- 7
- Pages
- 1589-1616
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4393251580
- Cited by
- 540
- References
- 256
- FWCI
- 82.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.